PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21109434-0	2011	Structure-activity relationship (SAR) of the alpha-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.	1,2,3,4-tetrahydroisoquinoline	80-102	integrin subunit alpha L	Homo sapiens	118-123	
24900456-4	2012	In this letter, we describe the discovery of a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist (SAR 1118) and its development as an ophthalmic solution for treating dry eye.	1,2,3,4-tetrahydroisoquinoline	54-76	integrin subunit alpha L	Homo sapiens	92-97	
24900456-4	2012	In this letter, we describe the discovery of a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist (SAR 1118) and its development as an ophthalmic solution for treating dry eye.	1,2,3,4-tetrahydroisoquinoline	78-82	integrin subunit alpha L	Homo sapiens	92-97	
21109434-0	2011	Structure-activity relationship (SAR) of the alpha-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.	1,2,3,4-tetrahydroisoquinoline	104-108	integrin subunit alpha L	Homo sapiens	118-123	
21109434-1	2011	This letter describes the structure-activity relationship (SAR) of the "right-wing" alpha-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.	1,2,3,4-tetrahydroisoquinoline	119-141	integrin subunit alpha L	Homo sapiens	157-162	
21109434-1	2011	This letter describes the structure-activity relationship (SAR) of the "right-wing" alpha-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.	1,2,3,4-tetrahydroisoquinoline	143-147	integrin subunit alpha L	Homo sapiens	157-162